Showing results (101-110 of 140) with videos related to
Sort By:
Pageof 14
Archives Des Maladies Du Coeur Et Des Vaisseaux|June 1, 1992
[Peripheral calcific embolism after percutaneous mitral valvuloplasty]G Montalescot, G Drobinski, D Thomas, et al.Clinical Pharmacology and Therapeutics|February 18, 1998
Population pharmacokinetic-pharmacodynamic analysis of fluindione in patientsF Mentré, F Pousset, E Comets, et al.Circulation|November 1, 1990
Thromboxane receptor blockade prevents pulmonary hypertension induced by heparin-protamine reactions in awake sheepG Montalescot, E Lowenstein, M L Ogletree, et al.International Journal of Cardiology|August 8, 1997
Plasma homocysteine and the extent of atherosclerosis in patients with coronary artery diseaseG Montalescot, A Ankri, B Chadefaux-Vekemans, et al.Archives Des Maladies Du Coeur Et Des Vaisseaux|November 22, 2005
[Prevalence of asymptomatic atherothrombotic lesions and risk of vascular events in patients with documented coronary artery disease]J P Collet, Y Allali, M Borentain, et al.Archives Des Maladies Du Coeur Et Des Vaisseaux|June 1, 1993
[Effects of ultrasonic energy on blood clots in vitro]G Drobinski, F Philippe, C Bucherer, et al.Journal of the American College of Cardiology|November 1, 1994
Endothelin-1 in patients with coronary heart disease undergoing cardiac catheterizationG Montalescot, I Viossat, P E Chabrier, et al.Heart (British Cardiac Society)|March 27, 1999
Spontaneous late improvement of myocardial viability in the chronic infarct zone is possible, depending on persistent TIMI 3 flow and a low grade stenosis of the infarct arteryM Faraggi, G Montalescot, L Sarda, et al.Circulation|November 1, 1991
Evaluation of thromboxane production and complement activation during myocardial ischemia in patients with angina pectorisG Montalescot, G Drobinski, J Maclouf, et al.Archives Des Maladies Du Coeur Et Des Vaisseaux|July 1, 1993
[Neurohormonal profile in aortic valve stenosis]J F Ramirez-Gil, G Drobinski, A Carayon, et al.Pageof 14